Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
NKGen Biotech, Inc. (NKGN) had Return on Equity of 63.35% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-44.29M |
|
-- |
|
-- |
|
$26.97M |
|
$-26.97M |
|
$-17.27M |
|
$-44.23M |
|
$-44.23M |
|
$-44.29M |
|
$-44.29M |
|
$-44.29M |
|
$-44.29M |
|
$-26.97M |
|
$-25.65M |
|
28.83M |
|
28.83M |
|
$-1.54 |
|
$-1.54 |
|
| Balance Sheet Financials | |
$2.46M |
|
$13.30M |
|
$13.77M |
|
$16.23M |
|
$57.97M |
|
$10.84M |
|
$28.17M |
|
$86.14M |
|
$-69.91M |
|
$-69.91M |
|
$-69.91M |
|
44.24M |
|
| Cash Flow Statement Financials | |
$-20.88M |
|
$-0.01M |
|
$20.85M |
|
$0.28M |
|
$0.23M |
|
$-0.04M |
|
$4.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.04 |
|
-- |
|
-- |
|
-0.18 |
|
-0.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.89M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
63.35% |
63.35% |
|
-272.85% |
|
74.98% |
|
$-1.58 |
|
$-0.72 |
|
$-0.72 |
|